Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind crossover study of Biostate SP in haemophilia A
2008-001104-23Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Biostate SP in hemophilia A (2 arms), sponsored by CSL Limited. Primary endpoints: Primary efficacy endpoint and Safety. Started Jan 2009; status: completed.
02
Drugs
Biostate SP
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-001104-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001104-23.